Literature DB >> 19528510

Apurinic/apyrimidinic endonuclease (APE1) gene polymorphisms and lung cancer risk in relation to tobacco smoking.

Bedia Agaçhan1, Ozlem Küçükhüseyin, Pinar Aksoy, Akif Turna, Ilhan Yaylim, Uzay Görmüs, Arzu Ergen, Umit Zeybek, Burak Dalan, Turgay Isbir.   

Abstract

BACKGROUND: Polymorphisms altering DNA repair capacity may lead to synergistic effects with tobacco carcinogen-induced lung cancer risk. Based on this hypothesis, the relationship between APE1 polymorphism, smoking and the risk of lung cancer was explored.
MATERIALS AND METHODS: The distribution of the APE1 Asp148Glu polymorphisms in 98 lung cancer patients and 67 healthy individuals were compared using PCR-RFLP analysis.
RESULTS: Individuals carrying the APE1 Asp148Glu heterozygous and homozygous variant genotype had a 3.23-fold increased risk of lung cancer compared with these carrying the wild-type (Asp/Asp) genotype (p<0.0001), and those carrying the 148Glu homozygous genotype had a 3.17-fold increased risk (p=0.023). When stratified by smoking status, carriers of the Glu allele of APE1 were at a statistically increased risk of lung cancer among smokers (p=0.001).
CONCLUSION: A statistically significant interaction of current smoking status with APE1 Asp148Glu polymorphism was found. These results suggest that the presence of one or two APE1 Glu allele was associated with the risk of developing lung cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528510

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  17 in total

1.  APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis.

Authors:  Ya-Nan Ji; Ping Zhan; Jing Wang; Li-Xin Qiu; Li-Ke Yu
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

2.  The association of APE1 Asp148Glu gene polymorphisms and lung cancer risk: an updated meta-analysis.

Authors:  Wen Chen; Qin Wang; Mang Liu; Xiao-bing Ding
Journal:  Tumour Biol       Date:  2013-12-06

3.  Genetic polymorphism of APE1 rs1130409 can contribute to the risk of lung cancer.

Authors:  Feng Jin; Chengyuan Qian; Yi Qing; Zhimin Zhang; Ge Wang; Jinlu Shan; Nan Dai; Zheng Li; Dong Wang
Journal:  Tumour Biol       Date:  2014-04-06

Review 4.  Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk.

Authors:  B Karahalil; V A Bohr; D M Wilson
Journal:  Hum Exp Toxicol       Date:  2012-09-27       Impact factor: 2.903

Review 5.  Base excision repair and cancer.

Authors:  Susan S Wallace; Drew L Murphy; Joann B Sweasy
Journal:  Cancer Lett       Date:  2012-01-15       Impact factor: 8.679

6.  APE1 Asp148Glu polymorphism and lung cancer susceptibility.

Authors:  Liyun Cai; Yingjv Fu; Yuanyue Zhang
Journal:  Tumour Biol       Date:  2014-02-13

7.  Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Wu Wei; Xiao-Feng He; Jiang-Bo Qin; Jiao Su; Shao-Xia Li; Yi Liu; Ying Zhang; Wei Wang
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

Review 8.  Genetic susceptibility to lung cancer--light at the end of the tunnel?

Authors:  Ariela L Marshall; David C Christiani
Journal:  Carcinogenesis       Date:  2013-01-24       Impact factor: 4.944

9.  Evaluating the association of polymorphisms in the HAP1 gene with lung cancer risk: a meta-analysis.

Authors:  Wei Wang; Haicheng Yan; Qiang Zhang; Wei Song; Haina Li; Jun Xu
Journal:  Tumour Biol       Date:  2014-08-01

Review 10.  The association of APE1 -656T > G and 1349 T > G polymorphisms and cancer risk: a meta-analysis based on 37 case-control studies.

Authors:  Bin Zhou; Hailin Shan; Ying Su; Kai Xia; Xiaxia Shao; Weidong Mao; Qing Shao
Journal:  BMC Cancer       Date:  2011-12-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.